AJMC May 14, 2021
Despite expanded use of precision medicine, there remain a myriad of barriers hindering its implementation in day-to-day practice.
Community oncology practices and the patients they care for can greatly benefit from the use of precision medicine (PM). In addition, as the cost of next-generation sequencing (NGS) has dropped, its use in clinical practice and research has expanded rapidly.
However, there remain a myriad of barriers that have hindered the implementation of PM and NGS in day-to-day practice, according to an article published in Targeted Oncology®.
Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care Associates and president of the Community Oncology Alliance, coauthored the paper.
“Factors like integration into practice guidelines, lack of consensus and standardization between different stakeholders...
Today's Sponsors
Today's Sponsor